Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section

Marco V. Corniola; Pierre-Hugues Roche; Michaël Bruneau; Luigi Cavallo; Roy T Daniel; Mahmoud Messerer; Sebastien Froelich; Paul A.  Gardner; Fred  Gentili; T Kawase; Dimitrios Paraskevopoulos; Jean Régis; Henry W S Schroeder; Theodore H.  Schwartz; M Sindou; JF Cornelius; Marcos Tatagiba; Torstein R Meling

doi:doi.org/10.1016/j.bas.2022.100864

Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section

Marco V. Corniola, Pierre-Hugues Roche, Michaël Bruneau, Luigi Cavallo, Roy T Daniel, Mahmoud Messerer, Sebastien Froelich, Paul A. Gardner, Fred Gentili, T Kawase, Dimitrios Paraskevopoulos, Jean Régis, Henry W S Schroeder, Theodore H. Schwartz, M Sindou, JF Cornelius, Marcos Tatagiba, Torstein R Meling

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

Introduction: The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable and the efficacy of
their treatments is challenging due to their indolent evolution, variations and fluctuations of symptoms, heterogeneity
of classifications and lack of randomized controlled trials. Here, a dedicated task force provides a
consensus statement on the overall management of CSMs.
Research question: To determine the best overall management of CSMs, depending on their clinical presentation,
size, and evolution as well as patient characteristics.
Material and methods: Using the PRISMA 2020 guidelines, we included literature from January 2000 to December
2020. A total of 400 abstracts and 77 titles were kept for full-paper screening.
Results: The task force formulated 8 recommendations (Level C evidence). CSMs should be managed by a highly
specialized multidisciplinary team. The initial evaluation of patients includes clinical, ophthalmological, endocrinological
and radiological assessment. Treatment of CSM should involve experienced skull-base neurosurgeons
or neuro-radiosurgeons, radiation oncologists, radiologists, ophthalmologists, and endocrinologists.
*

Original language	English
Article number	100864
Number of pages	16
Journal	Brain and spine
Volume	2
DOIs	https://doi.org/doi.org/10.1016/j.bas.2022.100864
Publication status	Published - 21 Jan 2022

Bibliographical note

Publisher Copyright:
© 2022 The Authors

Copyright:
Copyright 2023 Elsevier B.V., All rights reserved.

Access to Document

doi.org/10.1016/j.bas.2022.100864

Cite this

Corniola, M. V., Roche, P-H., Bruneau, M., Cavallo, L., Daniel, R. T., Messerer, M., Froelich, S., Gardner, P. A., Gentili, F., Kawase, T., Paraskevopoulos, D., Régis, J., Schroeder, H. W. S., Schwartz, T. H., Sindou, M., Cornelius, JF., Tatagiba, M., & Meling, T. R. (2022). Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section. Brain and spine , 2, [100864]. https://doi.org/doi.org/10.1016/j.bas.2022.100864

Corniola, Marco V. ; Roche, Pierre-Hugues ; Bruneau, Michaël ; Cavallo, Luigi ; Daniel, Roy T ; Messerer, Mahmoud ; Froelich, Sebastien ; Gardner, Paul A. ; Gentili, Fred ; Kawase, T ; Paraskevopoulos, Dimitrios ; Régis, Jean ; Schroeder, Henry W S ; Schwartz, Theodore H. ; Sindou, M ; Cornelius, JF ; Tatagiba, Marcos ; Meling, Torstein R. / Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section. In: Brain and spine . 2022 ; Vol. 2.

@article{96d4ca47c85045158d7acc1ff487a339,

title = "Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section",

abstract = "Introduction: The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable and the efficacy oftheir treatments is challenging due to their indolent evolution, variations and fluctuations of symptoms, heterogeneityof classifications and lack of randomized controlled trials. Here, a dedicated task force provides aconsensus statement on the overall management of CSMs.Research question: To determine the best overall management of CSMs, depending on their clinical presentation,size, and evolution as well as patient characteristics.Material and methods: Using the PRISMA 2020 guidelines, we included literature from January 2000 to December2020. A total of 400 abstracts and 77 titles were kept for full-paper screening.Results: The task force formulated 8 recommendations (Level C evidence). CSMs should be managed by a highlyspecialized multidisciplinary team. The initial evaluation of patients includes clinical, ophthalmological, endocrinologicaland radiological assessment. Treatment of CSM should involve experienced skull-base neurosurgeonsor neuro-radiosurgeons, radiation oncologists, radiologists, ophthalmologists, and endocrinologists.*",

keywords = "Neurosurgery Cavernous sinus Meningioma Microsurgery Gross total resection Cranial nerves Radiosurgery Radiotherapy Pituitary Consensus statement Intracranial meningiomas Gammaknife",

author = "Corniola, {Marco V.} and Pierre-Hugues Roche and Micha{\"e}l Bruneau and Luigi Cavallo and Daniel, {Roy T} and Mahmoud Messerer and Sebastien Froelich and Gardner, {Paul A.} and Fred Gentili and T Kawase and Dimitrios Paraskevopoulos and Jean R{\'e}gis and Schroeder, {Henry W S} and Schwartz, {Theodore H.} and M Sindou and JF Cornelius and Marcos Tatagiba and Meling, {Torstein R}",

year = "2022",

month = jan,

day = "21",

doi = "doi.org/10.1016/j.bas.2022.100864",

language = "English",

volume = "2",

journal = "Brain and spine ",

issn = "2772-5294",

publisher = "Elsevier",

}

Corniola, MV, Roche, P-H, Bruneau, M , Cavallo, L, Daniel, RT, Messerer, M, Froelich, S, Gardner, PA, Gentili, F, Kawase, T, Paraskevopoulos, D, Régis, J, Schroeder, HWS, Schwartz, TH, Sindou, M, Cornelius, JF, Tatagiba, M & Meling, TR 2022, 'Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section', Brain and spine , vol. 2, 100864. https://doi.org/doi.org/10.1016/j.bas.2022.100864

Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section. / Corniola, Marco V.; Roche, Pierre-Hugues; Bruneau, Michaël ; Cavallo, Luigi; Daniel, Roy T; Messerer, Mahmoud; Froelich, Sebastien; Gardner, Paul A. ; Gentili, Fred ; Kawase, T; Paraskevopoulos, Dimitrios; Régis, Jean; Schroeder, Henry W S; Schwartz, Theodore H. ; Sindou, M; Cornelius, JF; Tatagiba, Marcos; Meling, Torstein R.

In: Brain and spine , Vol. 2, 100864, 21.01.2022.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section

AU - Corniola, Marco V.

AU - Roche, Pierre-Hugues

AU - Bruneau, Michaël

AU - Cavallo, Luigi

AU - Daniel, Roy T

AU - Messerer, Mahmoud

AU - Froelich, Sebastien

AU - Gardner, Paul A.

AU - Gentili, Fred

AU - Kawase, T

AU - Paraskevopoulos, Dimitrios

AU - Régis, Jean

AU - Schroeder, Henry W S

AU - Schwartz, Theodore H.

AU - Sindou, M

AU - Cornelius, JF

AU - Tatagiba, Marcos

AU - Meling, Torstein R

PY - 2022/1/21

Y1 - 2022/1/21

N2 - Introduction: The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable and the efficacy oftheir treatments is challenging due to their indolent evolution, variations and fluctuations of symptoms, heterogeneityof classifications and lack of randomized controlled trials. Here, a dedicated task force provides aconsensus statement on the overall management of CSMs.Research question: To determine the best overall management of CSMs, depending on their clinical presentation,size, and evolution as well as patient characteristics.Material and methods: Using the PRISMA 2020 guidelines, we included literature from January 2000 to December2020. A total of 400 abstracts and 77 titles were kept for full-paper screening.Results: The task force formulated 8 recommendations (Level C evidence). CSMs should be managed by a highlyspecialized multidisciplinary team. The initial evaluation of patients includes clinical, ophthalmological, endocrinologicaland radiological assessment. Treatment of CSM should involve experienced skull-base neurosurgeonsor neuro-radiosurgeons, radiation oncologists, radiologists, ophthalmologists, and endocrinologists.*

AB - Introduction: The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable and the efficacy oftheir treatments is challenging due to their indolent evolution, variations and fluctuations of symptoms, heterogeneityof classifications and lack of randomized controlled trials. Here, a dedicated task force provides aconsensus statement on the overall management of CSMs.Research question: To determine the best overall management of CSMs, depending on their clinical presentation,size, and evolution as well as patient characteristics.Material and methods: Using the PRISMA 2020 guidelines, we included literature from January 2000 to December2020. A total of 400 abstracts and 77 titles were kept for full-paper screening.Results: The task force formulated 8 recommendations (Level C evidence). CSMs should be managed by a highlyspecialized multidisciplinary team. The initial evaluation of patients includes clinical, ophthalmological, endocrinologicaland radiological assessment. Treatment of CSM should involve experienced skull-base neurosurgeonsor neuro-radiosurgeons, radiation oncologists, radiologists, ophthalmologists, and endocrinologists.*

KW - Neurosurgery Cavernous sinus Meningioma Microsurgery Gross total resection Cranial nerves Radiosurgery Radiotherapy Pituitary Consensus statement Intracranial meningiomas Gammaknife

UR - http://www.scopus.com/inward/record.url?scp=85137606628&partnerID=8YFLogxK

U2 - doi.org/10.1016/j.bas.2022.100864

DO - doi.org/10.1016/j.bas.2022.100864

M3 - Article

VL - 2

JO - Brain and spine

JF - Brain and spine

SN - 2772-5294

M1 - 100864

ER -

Management of cavernous sinus meningiomas: Consensus statement on behalf of the EANS skull base section

Abstract

Bibliographical note

Access to Document

Other files and links

Cite this